Stocks Health care NKTX
NASDAQ · Health careNkarta, Inc. (NKTX)
It posted a net loss of $117.3M. In fiscal 2025 capital spending exceeded operating cash flow by $89.9M. At June 30, 2026 it held $25M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Nkarta, Inc. does
Nkarta, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NKTX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$104.1M | -$1.41 | -$89.9M |
| 2024 | $0 | -$108.8M | -$1.60 | -$104.1M |
| 2023 | n/a | -$117.5M | -$2.40 | -$114.3M |
| 2022 | n/a | -$113.8M | -$2.61 | -$104.1M |
| 2021 | n/a | -$86.1M | -$2.62 | -$73M |
| 2020 | n/a | -$91.4M | -$5.44 | -$51M |
Latest SEC filings
What Nkarta, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- August 10, 2026
- June 11, 2026
- May 19, 2026Activist stake changed SCHEDULE 13D/A
- May 12, 2026Quarterly report 10-Q · period to March 31, 2026
- May 12, 2026
- April 23, 2026
- April 23, 2026Additional proxy material DEFA14A
- April 23, 2026Proxy statement DEF 14A
- April 3, 2026
Questions about NKTX
What does Nkarta, Inc. do?
Nkarta, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NKTX.
Is Nkarta, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $117.3M.
When did Nkarta, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026.
Similar companies
Follow NKTX
Get an email when Nkarta, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow NKTX: get an email when it filesWhere the numbers come from
Financial figures are the values Nkarta, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.